- Home
- ZENV vs NVNO Comparison
ZENV vs NVNO Comparison
Compare ZENV & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- NVNO
- Stock Information
- Founded
- ZENV 2005
- NVNO 1987
- Country
- ZENV Brazil
- NVNO United States
- Employees
- ZENV N/A
- NVNO N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- NVNO Medical/Dental Instruments
- Sector
- ZENV Technology
- NVNO Health Care
- Exchange
- ZENV Nasdaq
- NVNO Nasdaq
- Market Cap
- ZENV 79.2M
- NVNO 71.0M
- IPO Year
- ZENV 2021
- NVNO N/A
- Fundamental
- Price
- ZENV $1.46
- NVNO $4.26
- Analyst Decision
- ZENV
- NVNO
- Analyst Count
- ZENV 0
- NVNO 0
- Target Price
- ZENV N/A
- NVNO N/A
- AVG Volume (30 Days)
- ZENV 78.9K
- NVNO 91.8K
- Earning Date
- ZENV 09-04-2025
- NVNO 07-30-2025
- Dividend Yield
- ZENV N/A
- NVNO N/A
- EPS Growth
- ZENV N/A
- NVNO N/A
- EPS
- ZENV N/A
- NVNO N/A
- Revenue
- ZENV $181,911,572.00
- NVNO N/A
- Revenue This Year
- ZENV $8.58
- NVNO N/A
- Revenue Next Year
- ZENV $8.83
- NVNO N/A
- P/E Ratio
- ZENV N/A
- NVNO N/A
- Revenue Growth
- ZENV 23.99
- NVNO N/A
- 52 Week Low
- ZENV $1.02
- NVNO $2.03
- 52 Week High
- ZENV $3.03
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- ZENV 46.93
- NVNO 58.84
- Support Level
- ZENV $1.40
- NVNO $3.89
- Resistance Level
- ZENV $1.50
- NVNO $4.47
- Average True Range (ATR)
- ZENV 0.09
- NVNO 0.21
- MACD
- ZENV -0.01
- NVNO -0.00
- Stochastic Oscillator
- ZENV 36.36
- NVNO 70.31
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.